Literature DB >> 7953656

Differential effects of ginsenoside Rb1 and malonylginsenoside Rb1 on long-term potentiation in the dentate gyrus of rats.

K Abe1, S I Cho, I Kitagawa, N Nishiyama, H Saito.   

Abstract

Ginseng saponins are known to have various pharmacological actions on the central nervous system. In the present study, we investigated the effects of ginsenoside Rb1 (GRb1) and malonylginsenoside Rb1 (GRb1-m) on the induction of long-term potentiation (LTP) in the dentate gyrus using anesthetized rats. Injection (i.c.v.) of GRb1 did not affect the basal synaptic responses evoked by low-frequency test stimulation, but significantly attenuated the magnitude of LTP induced by strong tetanus (100 pulses at 100 Hz). The inhibitory effect of GRb1 depended on its doses (0.5-50 nmol, i.c.v.). On the other hand, GRb1-m did not affect the LTP induced by the strong tetanus, but facilitated the generation of LTP by the weak tetanus (20 pulses at 60 Hz) that produced only short-lasting potentiation in normal condition. The LTP-facilitating effect of GRb1-m was seen maximally at a dose of 5 nmol (i.c.v.) and diminished at a higher dose (50 nmol, i.c.v.). Since another ginseng saponin ginsenoside Rg1 did not affect the induction of LTP at all, the inhibition and facilitation of LTP induction are probably specific actions of GRb1 and GRb1-m, respectively. This is the first report providing direct evidence that ginseng saponins affect the activity-dependent synaptic plasticity in the brain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7953656     DOI: 10.1016/0006-8993(94)91042-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  PC-2, linear homoglucan with alpha-linkages, peripherally enhances the hippocampal long-term potentiation.

Authors:  M Smriga; H Saito; S Shibata; T Narui; T Okuyama; N Nishiyama
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

2.  Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study.

Authors:  M R Lyon; J C Cline; J Totosy de Zepetnek; J J Shan; P Pang; C Benishin
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

3.  Comparison of the Saponins in Three Processed American Ginseng Products by Ultra-High Performance Liquid Chromatography-Quadrupole Orbitrap Tandem Mass Spectrometry and Multivariate Statistical Analysis.

Authors:  Na Guo; Yuxin Bai; Xin Huang; Xiaokang Liu; Guangzhi Cai; Shuying Liu; Yunlong Guo; Jiyu Gong
Journal:  Int J Anal Chem       Date:  2022-04-26       Impact factor: 1.698

4.  Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study.

Authors:  Andrew Scholey; Anastasia Ossoukhova; Lauren Owen; Alvin Ibarra; Andrew Pipingas; Kan He; Marc Roller; Con Stough
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

Review 5.  Ginseng ginsenoside pharmacology in the nervous system: involvement in the regulation of ion channels and receptors.

Authors:  Seung-Yeol Nah
Journal:  Front Physiol       Date:  2014-03-19       Impact factor: 4.566

6.  Ginsenoside Rg1 modulates medial prefrontal cortical firing and suppresses the hippocampo-medial prefrontal cortical long-term potentiation.

Authors:  Mehdy Ghaeminia; Ramamoorthy Rajkumar; Hwee-Ling Koh; Gavin S Dawe; Chay Hoon Tan
Journal:  J Ginseng Res       Date:  2017-04-04       Impact factor: 6.060

7.  Cognition enhancing effect of panax ginseng in Korean volunteers with mild cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Key-Chung Park; Hui Jin; Renhua Zheng; Sehyun Kim; Seung-Eun Lee; Bo-Hyung Kim; Sung-Vin Yim
Journal:  Transl Clin Pharmacol       Date:  2019-09-30

Review 8.  Ginsenoside and Its Therapeutic Potential for Cognitive Impairment.

Authors:  Hui Feng; Mei Xue; Hao Deng; Shiqi Cheng; Yue Hu; Chunxiang Zhou
Journal:  Biomolecules       Date:  2022-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.